Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
Tansarli GS, Papaparaskevas J, Balaska M, Samarkos M, Pantazatou A, Markogiannakis A, Mantzourani M, Polonyfi K, Daikos GL. Tansarli GS, et al. Among authors: daikos gl. Int J Antimicrob Agents. 2018 Sep;52(3):397-403. doi: 10.1016/j.ijantimicag.2018.06.012. Epub 2018 Jun 28. Int J Antimicrob Agents. 2018. PMID: 29960007
Structures, locations, and transfer frequencies of genetic elements conferring high-level gentamicin resistance in Enterococcus faecalis isolates in Greece.
Daikos GL, Bamias G, Kattamis C, Zervos MJ, Chow JW, Christakis G, Petrikkos G, Triantafyllopoulou P, Alexandrou H, Syriopoulou V. Daikos GL, et al. Antimicrob Agents Chemother. 2003 Dec;47(12):3950-3. doi: 10.1128/AAC.47.12.3950-3953.2003. Antimicrob Agents Chemother. 2003. PMID: 14638507 Free PMC article.
Colistin in the treatment of life-threatening infections.
Pavleas J, Skiada A, Daikos GL, Rigas K, Mega A, Archondoulis N, Vernikos P, Salatas K, Thomopoulos G. Pavleas J, et al. Among authors: daikos gl. Int J Antimicrob Agents. 2006 Oct;28(4):374-6. doi: 10.1016/j.ijantimicag.2006.05.029. Epub 2006 Sep 11. Int J Antimicrob Agents. 2006. PMID: 16963234 No abstract available.
Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G, Markogiannakis A, Papaparaskevas J, Daikos GL, Stefanakos G, Zissis NP, Avlamis A. Petrikkos G, et al. Among authors: daikos gl. Int J Antimicrob Agents. 2007 Jan;29(1):34-8. doi: 10.1016/j.ijantimicag.2006.08.042. Int J Antimicrob Agents. 2007. PMID: 17189092
VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases.
Daikos GL, Karabinis A, Paramythiotou E, Syriopoulou VP, Kosmidis C, Avlami A, Gargalianos P, Tzanetou K, Petropoulou D, Malamou-Lada H. Daikos GL, et al. Int J Antimicrob Agents. 2007 Apr;29(4):471-3. doi: 10.1016/j.ijantimicag.2006.11.006. Epub 2007 Jan 16. Int J Antimicrob Agents. 2007. PMID: 17229554 No abstract available.
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.
Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, Georgousi K, Tzouvelekis LS, Tassios PT, Bamia C, Petrikkos G. Daikos GL, et al. Antimicrob Agents Chemother. 2009 May;53(5):1868-73. doi: 10.1128/AAC.00782-08. Epub 2009 Feb 17. Antimicrob Agents Chemother. 2009. PMID: 19223638 Free PMC article.
225 results